Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2004 1
2005 2
2006 2
2007 5
2008 10
2009 5
2010 6
2011 3
2012 9
2013 13
2014 11
2015 12
2016 10
2017 12
2018 11
2019 12
2020 6
Text availability
Article attribute
Article type
Publication date

Similar Articles for PMID: 31420350

109 results
Results by year
Filters applied: . Clear all
Page 1
Cardiovascular Safety and All-Cause Mortality of Methoxy Polyethylene Glycol-Epoetin Beta and Other Erythropoiesis-Stimulating Agents in Anemia of CKD: A Randomized Noninferiority Trial.
Locatelli F, Hannedouche T, Fishbane S, Morgan Z, Oguey D, White WB. Locatelli F, et al. Clin J Am Soc Nephrol. 2019 Dec 6;14(12):1701-1710. doi: 10.2215/CJN.01380219. Epub 2019 Aug 16. Clin J Am Soc Nephrol. 2019. PMID: 31420350
Erythropoiesis-stimulating agents for anaemia in adults with chronic kidney disease: a network meta-analysis.
Palmer SC, Saglimbene V, Mavridis D, Salanti G, Craig JC, Tonelli M, Wiebe N, Strippoli GF. Palmer SC, et al. Cochrane Database Syst Rev. 2014 Dec 8;2014(12):CD010590. doi: 10.1002/14651858.CD010590.pub2. Cochrane Database Syst Rev. 2014. PMID: 25486075 Free PMC article. Review.
Darbepoetin for the anaemia of chronic kidney disease.
Palmer SC, Saglimbene V, Craig JC, Navaneethan SD, Strippoli GF. Palmer SC, et al. Cochrane Database Syst Rev. 2014 Mar 31;(3):CD009297. doi: 10.1002/14651858.CD009297.pub2. Cochrane Database Syst Rev. 2014. PMID: 24683046 Review.
Maintenance treatment of renal anaemia in haemodialysis patients with methoxy polyethylene glycol-epoetin beta versus darbepoetin alfa administered monthly: a randomized comparative trial.
Carrera F, Lok CE, de Francisco A, Locatelli F, Mann JF, Canaud B, Kerr PG, Macdougall IC, Besarab A, Villa G, Kazes I, Van Vlem B, Jolly S, Beyer U, Dougherty FC; PATRONUS Investigators. Carrera F, et al. Nephrol Dial Transplant. 2010 Dec;25(12):4009-17. doi: 10.1093/ndt/gfq305. Epub 2010 Jun 3. Nephrol Dial Transplant. 2010. PMID: 20522670 Free PMC article. Clinical Trial.
Continuous erythropoiesis receptor activator (CERA) for the anaemia of chronic kidney disease.
Saglimbene VM, Palmer SC, Ruospo M, Natale P, Craig JC, Strippoli GF. Saglimbene VM, et al. Cochrane Database Syst Rev. 2017 Aug 7;8(8):CD009904. doi: 10.1002/14651858.CD009904.pub2. Cochrane Database Syst Rev. 2017. PMID: 28782299 Free PMC article. Review.
Efficacy and Long-Term Safety of C.E.R.A. Maintenance in Pediatric Hemodialysis Patients with Anemia of CKD.
Fischbach M, Wühl E, Reigner SCM, Morgan Z, Schaefer F. Fischbach M, et al. Clin J Am Soc Nephrol. 2018 Jan 6;13(1):81-90. doi: 10.2215/CJN.03570417. Epub 2017 Nov 2. Clin J Am Soc Nephrol. 2018. PMID: 29097481 Free PMC article. Clinical Trial.
Methoxy Polyethylene Glycol-Epoetin Beta as a Novel Erythropoiesis Stimulating Agent with Possible Nephroprotective and Cardiovascular Protective Effects in Non-Dialysis Chronic Kidney Disease Patients.
Piotr B, Mariusz S, Jacek R. Piotr B, et al. Curr Pharm Biotechnol. 2017;18(4):303-308. doi: 10.2174/1389201018666170127104801. Curr Pharm Biotechnol. 2017. PMID: 28137221 Review.
Intravenous methoxy polyethylene glycol-epoetin beta for haemoglobin control in patients with chronic kidney disease who are on dialysis: a randomised non-inferiority trial (MAXIMA).
Levin NW, Fishbane S, Cañedo FV, Zeig S, Nassar GM, Moran JE, Villa G, Beyer U, Oguey D; MAXIMA study investigators. Levin NW, et al. Lancet. 2007 Oct 20;370(9596):1415-21. doi: 10.1016/S0140-6736(07)61599-2. Lancet. 2007. PMID: 17950856 Clinical Trial.
109 results
Jump to page